Cargando…
MiR-192-5p reverses cisplatin resistance by targeting ERCC3 and ERCC4 in SGC7901/DDP cells
Cisplatin chemoresistance is a clinical obstacle in the treatment of gastric cancer (GC). Enhanced DNA repair capacity may lead to cisplatin resistance. However, the detailed molecular mechanism of GC cisplatin resistance specifically involving nucleotide excision repair (NER) is not clear. However,...
Autores principales: | Xie, Xiaoque, Huang, Nana, Zhang, Yiyin, Wei, Xiaoli, Gao, Mengru, Li, Min, Ning, Jie, Liu, Wei, Zhao, Qihong, Wang, Hua, Gu, Kangsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400793/ https://www.ncbi.nlm.nih.gov/pubmed/30854110 http://dx.doi.org/10.7150/jca.25814 |
Ejemplares similares
-
SKI-II reverses the chemoresistance of SGC7901/DDP gastric cancer cells
por: LIU, YING, et al.
Publicado: (2014) -
MicroRNA-200c reverses drug resistance of human gastric cancer cells by targeting regulation of the NER-ERCC3/4 pathway
por: Li, Min, et al.
Publicado: (2019) -
Synergistic Effect of Zuo Jin Wan on DDP-Induced Apoptosis in Human Gastric Cancer SGC-7901/DDP Cells
por: Tang, Qing-Feng, et al.
Publicado: (2014) -
Silencing of the ARK5 gene reverses the drug resistance of multidrug-resistant SGC7901/DDP gastric cancer cells
por: Wan, Hongtao, et al.
Publicado: (2020) -
Overexpression of the Survivin gene in SGC7901 cell resistance to cisplatin
por: DONG, HANZHANG, et al.
Publicado: (2014)